Recent News

• 01.08.2026 - Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025
• 12.23.2025 - Merit Medical to Participate at the J.P. Morgan Healthcare Conference
• 11.13.2025 - Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
• 11.05.2025 - Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
• 11.03.2025 - Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

Recent Filings

• 01.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.08.2026 - 8-K Current report
• 01.08.2026 - EX-99.1 EX-99.1
• 01.06.2026 - 144 Report of proposed sale of securities
• 11.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.25.2025 - 144 Report of proposed sale of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.21.2025 - 144 Report of proposed sale of securities
• 11.20.2025 - 4 Statement of changes in beneficial ownership of securities